“We are maintaining mid-single digit adjusted earnings growth expectation over the remainder of the near-term.”

In context

“ear. For MetLife Holdings, we are expecting adjusted PFOs to decline by approximately 13% to 15% in 2024 and then declining 4% to 6% annually thereafter. And we are lowering the adjusted earnings guidance range to $700 million to $900 million in 2024 to reflect the foregone earnings from the reinsurance transaction as well as lower expected PE returns and natural runoff of the business. Now, let’s look at the near-term guidance of our businesses outside the U.S. on Page 15. For Asia, we expect the recent sales momentum to continue and generate mid-single digit growth over the near-term. In addition, we expect general account AUM to maintain mid-single digit growth. We are expecting adjusted earnings to grow roughly 20% in 2024 as we assume VII to have a greater impact throughout the year. We are maintaining mid-single digit adjusted earnings growth expectation over the remainder of the near-term. For Latin America, we expect both adjusted PFOs and adjusted earnings to grow by high single digits over the near-term. Finally, for EMEA, we’re expecting sales to grow mid- to high-single digits and adjusted PFOs to grow mid-single digits over the near-term. The forward curve assumes a strengthening of the U.S. dollar relative to most currencies in EMEA. As such, we project EMEA’s adjusted earnings run rate to be roughly $60 million to $65 million per quarter in 2024 and then grow by mid-single digits in 2025 and 2026 based on the forward curve for these currencies. Let me conclude by saying that MetLife delivered a solid quarter to close out another strong year. The underlying strength of our business fundamentals remains on display with strong top line growth coupled with disciplined u”